Round 2 in Boehringer's US re­or­ga­ni­za­tion will claim an­oth­er 244 jobs, in­clud­ing small mol­e­cule group

Boehringer In­gel­heim is once again tak­ing out its bud­get ax and hack­ing away jobs. Five months af­ter the com­pa­ny told me that it was chop­ping 725 jobs out of its US struc­ture, the Ger­man phar­ma com­pa­ny is hack­ing out an­oth­er 244 po­si­tions, in­clud­ing 120 in­volved in small mol­e­cule dis­cov­ery re­search in Con­necti­cut and bring­ing the to­tal to close to a thou­sand.

The rest of the cuts in­clud­ed 60 staffers in var­i­ous func­tions with an­oth­er 64 sales jobs be­ing elim­i­nat­ed as well.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER